In addition, unlike in adult GBM, the addition of temozolomide in PED-GBM did not show a survival benefit compared to radiation therapy alone, even in tumors with methylated O6methylguanine-DNA-methyltransferase (MGMT) promoter (9). The gene discussed is MGMT; the disease is glioblastoma.